PERFORMANCE QUALIFICATION PROTOCOL HVAC SYSTEM

Size: px
Start display at page:

Download "PERFORMANCE QUALIFICATION PROTOCOL HVAC SYSTEM"

Transcription

1 Page 1 of 24 PERFORMANCE QUALIFICATION PROTOCOL FOR HVAC SYSTEM Signing of this Performance Qualification Protocol indicates agreement with the Validation Master Plan approach of the equipment. Further if any changes in this protocol are required, protocol will be revised and duly approved.

2 Page 2 of 24 PREPARED BY: Written By: Reviewed By: ABB Company Name Signature Date Jacobs Engineering CHECKED BY: Organization Abc Pharmaceuticals (User Dept.) Abc Pharmaceuticals (Engg. Dept.) Abc Pharmaceuticals (QA Dept.) Name Designation Signature Date APPROVED BY: Organization Abc Pharmaceuticals (HOD QA Dept.) Abc Pharmaceuticals (Plant Head) Name Designation Signature Date

3 Page 3 of 24 TABLE OF CONTENTS 1 OBJECTIVE SCOPE RESPONSIBILITIES SYSTEM DESCRIPTION DOCUMENTATION REQUIREMENTS DATA COLLECTION CHANGE CONTROL PRE-QUALIFICATION REQUIREMENTS System Pre-requisites Test Equipment Calibration TESTS AND CHECKS Differential Pressure Monitoring Objective Test Method Acceptance Criteria Test Material/Equipment Temperature and Humidity monitoring Objective Test Method Acceptance Criteria Test Material/Equipment Airborne Particulate Testing Objective Test Method Acceptance Criteria Test Material/Equipment Microbiological Environmental Monitoring Objective Test Method Acceptance Criteria... 15

4 Page 4 of Test Material/Equipment Recovery Test Objective Method Acceptance Criterion Test material/ Equipment Test Program and Sampling Points Test Results CHECKLIST OF ALL TESTS AND CHECKS VARIANCE SHEET REFERENCES LIST OF APPENDICES SUMMARY (ABC ABC) APPROVALS... 24

5 Page 5 of 24 1 OBJECTIVE The objectives of this Performance Qualification (PQ) are as follows: To verify that the equipment performs in accordance with the design and user requirements as defined by set acceptance criteria and complies with relevant cgmp requirements. To demonstrate that the system will perform reproducibly and consistently within its operating range Following execution of the protocol a summary report will be written and approved. All results, conclusions, exceptions and variances will be addressed and final disposition of the equipment will be stated. Successful completion of this protocol and approval of the summary report will verify that the meets all the acceptance criteria and is ready for GMP use. 2 SCOPE This protocol covers all aspects of Performance Qualification for the serving the Abc Pharmaceuticals Limited, Abc, Himachal Pradesh (India); Tablets, Capsules and Liquid Orals Manufacturing Facility. Scope incorporates qualification of all HVAC system components. This protocol will define the methods and documentation used to qualify the for PQ. 3 RESPONSIBILITIES All work is to be performed under Abc Pharmaceuticals Limited, Abc, Himachal Pradesh (India) oversight and according to ABC approved procedures. ABB Personnel The following are the responsibilities of Jacobs Engineering Validation Personnel: Writes the protocol using the approved template. Ensures that the protocol is in compliance with current ABC policies and procedures. Ensures that the content is sufficient, clearly defined technically sound and accurate. Ensures compliance with design specifications. Submits the draft protocol for review. Makes any necessary corrections to the protocol and answers queries from the reviewers. Submits the corrected protocol for approval

6 Page 6 of 24 Jacobs Engineering Review the protocol as submitted by ABB and ensure compliance with design specifications. Abc Pharmaceuticals Limited (ABC) Validation Personnel The following are the primary responsibilities of the ABC Validation Personnel: Overall CGMP compliance for IQ Review and Pre-Approval of this IQ Protocol Issue of controlled copies of the protocol for execution Execution of this IQ protocol Document Control of this IQ Protocol until such document is completed, approved and after. Regulatory Compliance Review of the completed IQ Protocol Review and Approval of the executed IQ Protocol Training (of ABC and contract staff) and documentation of training for any ABC procedures required for execution of the IQ. 4 SYSTEM DESCRIPTION This plant is designed as per cgmp of national and international regulatory guidelines. The system designed and installed shall meet the requirement of various processing zones with regard to following parameters, which has been specified in the URS. URS No.: UR/UG/17. Dry Bulb Temperature (Room Temperature) Relative Humidity Pressure differentials Class of Cleanliness, Function of is to provide environmental Conditions suitable for process ongoing in different area, Raw Material / Finished Goods storage conditions & Human comfort. Complete is controlled and monitored with BMS. System Overview The system has been categorized in three area classifications namely O, E and F, based on the cleanliness maintained. O area is the process area where product is exposed to the environment. E area is the area where product is enclosed and not exposed to the environment

7 Page 7 of 24 F area is the Non-critical areas not directly related to production Both O and E area are supplied with Terminal EU 9 filters with 99.5% efficiency down to 3μ ; the difference being that in O area the number of air changes maintained at a minimum 20 per hour and in E area the number of air changes maintained as per heat load requirement. Gowning shall be required for O and E areas. Complete Production area is divided in different Zones as per inside design conditions, class of cleanness as per the requirement of process. Dedicated AHUs are provided for various zones to considering containment aspects as cgmp. Details of various zones are given in the enclosed drawings. Once through system has considered for AHU s serving multi-product areas, areas where solvents are present and high dust generation areas. Once through AHU are provided with Heat Recovery Wheel to recover the waste Tonnage of Refrigeration. System has been designed considering Heat Loads, minimum air changes as applicable and air infiltration/ exfiltration from openings. Room relative pressures have been maintained to avoid cross contamination. Air locks have been provided as additional protection for cross contamination with Air Lock acting source of air between two adjacent areas where protection is desirable. For pressure balancing of entire system, the impact of door gaps & other openings on infiltration and ex-filtration has been considered for all areas while designing the HVAC system to maintain pressure differentials. Door interlocks for Air Lock rooms have been provided. Recovery time shall be established. The HVAC system shall operate with dust extraction system simultaneously to control dust levels in various areas. Accordingly, the impact of Air removal through dust extraction system has been considered while designing the HVAC system. Environmental Monitoring - Room Pressures, Temperature and RH Room conditions shall be monitored by manual recording of the pressures, temperatures and RH. Pressure readings are taken from Magnehelic Gauges, Dry Bulb and Wet Bulb indicating thermometers for Room Temperatures and RH. These measuring devices are installed locally in the room where environmental conditions are to be monitored. Data Logging by BMS

8 Page 8 of 24 Sensors for Temperature, RH, and Differential Pressure etc. as required shall be installed to log the values in BMS works station for trend analysis. These shall be in addition to local environmental monitoring. Control Philosophy Temperature Control of Room Temp. (Summer) To control the temperature of room there will be one two way control valve in chilled water line of AHU and temp sensor will be installed in the room / Return Air duct. By sensing the room temp/return air temp. chilled water control valve will modulate the chilled water flow as per the requirement. Control of Room Temp. (Winter) To control the temp of room there will be one two way control valve in hot water line of AHU and temp sensor will be installed in the room / Return Air duct. By sensing the room temp/return air temp. hot water control valve will modulate the hot water flow as per the requirement. Relative Humidity Control of Room RH (< 55% RH) AHU is equipped with hot water coil and hot water coil is with two way control valve and RH sensor is installed in the room/return air path. By sensing the room RH two way control valve will modulate the hot water as required to control the RH. Control of Room RH (< 40%) Area where RH below 40% is required dedicated dehumidifier are provided there. Desicant in the dehumidifier absorb the humidity and maintain the RH as per the requirement. Pressures By manually adjusting air flow quantities with the help of dampers.

9 Page 9 of 24 Future Provisions for It is envisaged to install terminal HEPA filters in place of EU-9 terminal super fine filters for O and E areas. Hence, all parts & equipment installed shall be compatible for higher-pressure drops due to change in filters. Chilled Water System for HVAC and Process 5 Nos. (4 working + 1 standby), each of 375 TR capacity water cooled screw chillers are being installed with primary & Secondary Pumping system to provide chilled water to AHUs & process equipments at various locations. Secondary Chilled Water Pumping System has been provided with VFD and pump logic controller for flow control of secondary chilled water as per actual HVAC and Process Load requirement. 2 Nos. (1working + 1 standby), each of 440 Kilo Watt plate type hot water calorifier (Hot Water Generator) are being installed for pumping hot water to all AHU. Hot water System is equipped with Hot Water Pumps with Variable Frequency Drive (VFD). 1 No. cooling tower with 5 cells (4 working + 1standby), each of capacity 1650 Gallons Per minute each cell to reject heat dissipated by chillers and air compressors are being installed. Both the CHW and HW piping on the service floor shall be designed to follow the reverse return method. This is to ensure that pressure drop between the off take from supply header, upto return header, is same for all for AHU s. This will help in correct quantity of water going in all AHU s at equal pressure differential. 5 DOCUMENTATION REQUIREMENTS The PQ File should include: This PQ Protocol. All printouts and handouts generated during the qualification procedure. All laboratory test results or their referenced location. All executed routine check sheets. A Signature Sheet [Appendix 1], where all people, performing the qualification tests, are listed. Any change control actions that may have occurred during the qualification activities. Any variances, exceptions or investigation reports generated during the qualification activities. 6 DATA COLLECTION All individuals executing this Protocol shall complete the Signature Sheet [Appendix I]. All personnel shall have suitable documented training or experience.

10 Page 10 of 24 All approvals shall be made in BLUE ink. All data entry shall be made in BLUE ink. All corrections to this Protocol, which are not retyped, are to be made in BLUE ink. All written corrections to this Protocol or to data entered in this Protocol should be made by using a single line to delete the error. The person who makes the correction shall initial and date it and add comment to explain reason for correction. After performing the qualification tests, collect all relevant printouts, check sheets, Laboratory test results and certificates and retain for inclusion in the PQ File. If more Data Sheets or Variance Sheets are required, they are to be attached to this Protocol as Appendices and to be listed in Section 13. List of Appendices. 7 CHANGE CONTROL Any changes or modifications to the system shall be performed in accordance with the ABC Project Change Control Procedure (SOP No: BQA-011) Change Control Forms raised during the execution of this PQ will be filed along with the protocol. An assessment will be made for each change to determine whether or not any re-validation is required. 8 PRE-QUALIFICATION REQUIREMENTS The results of any tests should meet the limits and acceptance criteria specified in the test documents. Any deviations (as per BQA-017) or issues should be rectified and documented prior to PQ commencing. Open action items resulting from these tests shall be listed in the Comments section.

11 Page 11 of System Pre-requisites No. 1 2 Description of Pre-requisite Verify that the OQ of the Dispensing Booth has been executed and approved. OQ Protocol Document No: OQ/F/HVC-01/00 Verify that the IQ/OQ summary report for the Dispensing Booth has been approved. IQ/OQ summary report document No. Completed Yes or No Verified By Date Yes/No* Yes/No* Note:- * -Circle one, which is appropriate.

12 Page 12 of Test Equipment Calibration Review the calibration status for the test equipment to be utilised and record the calibration due dates in the table below. All equipment / instrumentation must remain within the calibration due date for the duration of PQ test for which the item is used. If a due date potentially occurs during the testing period then the instrument must be recalibrated before it can be utilised. Equipment Name Equipment Owner Equipment Number Due Date Signature Date Reviewed by Date

13 Page 13 of 24 9 TESTS AND CHECKS 9.1 Differential Pressure Monitoring Objective The objective of this test is to show that the differential pressures between rooms are within designed values Test Method Use installed pressure gauges or either external pressure-measuring device for recording pressures. Monitor the pressure between rooms for a minimum of 5 days. Perform this monitoring under operational conditions Acceptance Criteria The relative differential pressures between rooms must be within the design values. The differential pressures between rooms to meet criteria as defined in the Room Book Test Material/Equipment Installed pressure gauges External pressure measuring device 9.2 Temperature and Humidity monitoring Objective The objective of this test is to prove that the temperature and humidity in the production areas are within acceptable limits Test Method Record the temperature and the humidity by using a dry bulb and wet bulb thermometer. Monitor the temperature and the humidity for a minimum of 5 days. Perform this monitoring under operational conditions Acceptance Criteria Temperatures should be within temperature range as defined in Room Book.

14 Page 14 of Test Material/Equipment Dry Bulb and Wet Bulb Thermometer 9.3 Airborne Particulate Testing Objective The objective of this test is to verify that the HVAC facilities can provide the required clean room classifications as defined in IS standards for Class 10,000 & Class 1,00,000(ISO Class 7 & ISO Class 8 ) Test Method Set up the particle counter according to appropriate test equipment operating procedures at the first sample point. Monitor the particles daily for a minimum of 5 days. Perform this monitoring under rest conditions. Repeat the measurement for every sample point. Sample points and frequency of testing see in chapter 9.6 Test Program and Sampling Points Acceptance Criteria Class 10,000 Grade B Not more than particles 0.5 microns per m 3 and not more than particles 5 microns per m 3. Class 1,00,000 Grade C Not more than particles 0.5 microns per m 3 and not more than particles 5 microns per m Test Material/Equipment Particle Counter

15 Page 15 of Microbiological Environmental Monitoring Objective The objective of this test is to verify that the HVAC facilities can provide the required cleanliness with regard to microbiological contamination as defined in ISO Standards & EU Standards for Class 1,00,000 ( ISO 8) & Class 10,000 ( ISO 7 ) area Test Method Set up the air sampler according to appropriate test equipment operating procedures at the first sample point. Monitor the particles daily for a minimum of 5 days. Perform this monitoring under operational conditions. Repeat the measurement for every sample point. Sample points and frequency of testing see in chapter 9.6 Test Program and Sampling Points Acceptance Criteria ISO Class 7 Not more than 10 colony forming units per m 3 of air sampled. Grade 10,000 ISO Class 8 Not more than 100 colony forming units per m 3 of air sampled. Class 1,00, Test Material/Equipment Air sampler

16 Page 16 of Recovery Test Objective This test is performed to determine the ability of the installation to eliminate air borne particles so that subsequent sampling/ dispensing operation can be performed without contaminating the lot Method This test shall be performed at as built condition. Setup the particle counter in accordance with the manufacturer s instructions and the apparatus calibration certificate. Place the Discrete Particle Counter Probe at the testing point. Adjust the single sample volume to the same value used for determining the class of cleanliness. The delay time of the counter from starting each count to the output recording should be adjusted to no more than 10 seconds. As far as possible, the particle size used shall be same as that used for the determination of cleanliness class. Generate particles to 100 times the target level. Determine the recovery time with recovery rate test to target level Acceptance Criterion Recovery time is given as tr all is the recovery time of whole zone tr i is the recovery time of each location N is the number of tested locations tr all = N ( 1/ tr i ) Recovery time shall be less than 10 minutes Test material/ Equipment Aerosol Generator Discrete Particle Counter The apparatus should have valid calibration certificate.

17 Page 17 of Test Program and Sampling Points Calculate the number of sample points for particulate testing according to ISO standards. Use less sample points for temperature, humidity and microbiological monitoring. Mark the location of every sample point in actual site drawings. 9.7 Test Results Summarize the test results obtained in Appendix, Test Results Summary. Report any deviations / non conformances in Appendix, Deviation / Non-Conformance Report. Any out-of specification results shall be investigated.

18 Page 18 of CHECKLIST OF ALL TESTS AND CHECKS This checklist is provided to ensure that all tests or checks required for this protocol have been executed. Reference No. Tests or Checks Executed [Y/N] Comment 9.1 Differential Pressure Monitoring 9.2 Temperature and Humidity Monitoring 9.3 Air Borne Particulate Monitoring 9.4 Microbiological Monitoring 9.5 Recovery Test Environmental

19 Page 19 of VARIANCE SHEET Report any deviations from the acceptance criteria or exceptions from protocol instructions in the Record Sheet as described in SOP No: BQA-017 Handling of Deviations. Record the total number of exceptions / deviations reported during the qualification activities of this Protocol. Record the Deviation Number and Title in the Table below. Include all Deviation Record Sheets in the IQ File. TOTAL NO. OF VARIANCES = Variance No. Variance Title Status Comments: Signed: Date: Reviewed by Date

20 Page 20 of REFERENCES The Principle Reference is the following Master Validation Plan for Abc Pharmaceuticals Limited Tablets, Capsules and Liquid Orals Manufacturing Facility, VMP/00, Revision 00. Schedule M Good Manufacturing Practices and Requirements of Premises, Plant and Equipment for Pharmaceutical Products. WHO Essential Drugs and Medicines Policy, QA of Pharmaceuticals, Vol 2 Good Manufacturing Practices and Inspection. The following references are used to give addition guidance FDA/ISPE Baseline Pharmaceutical Engineering Guide-Volume 5:- Commissioning and Qualification Guide, First Edition / March Code of Federal Regulations (CFR), Title 21, Part 210, Current Good Manufacturing Practice (cgmp) in Manufacturing, Processing, Packing, or Holding of Drugs, General. April 1, Code of Federal Regulations (CFR), Title 21, Part 211, Current Good Manufacturing Practice (cgmp) for Finished Pharmaceuticals, April 1, EU Guide to Good Manufacturing Practice, Part 4, European Commission s working party on control of medicines and inspections document, Validation Master Plan, Design Qualification, Installation & Operational Qualification, Non Sterile Process Validation, Cleaning Validation, October GAMP Guide, Validation of Automated Systems in Pharmaceutical Manufacture, Version 4.0, December SOP No BQA)-017- Handling of Deviations. SOP No BQA)-011- Change Control Procedure.

21 Page 21 of LIST OF APPENDICES Appendix No. 1 Signature Sheet Document Title

22 Page 22 of 24 SIGNATURE SHEET Appendix 1 Name Company Signature Initials Function / Activity

23 Page 23 of SUMMARY (ABC ABC)

24 Page 24 of APPROVALS The following approvals signify that the PQ is complete and acceptable. EXECUTED BY: Organization Name Designation Signature Date Vendor Abc Pharmaceuticals (User Dept.) Abc Pharmaceuticals (Engg Dept.) Abc Pharmaceuticals (QA Dept.) REVIEWED BY: Organization Abc Pharmaceuticals (HOD User Dept.) Abc Pharmaceuticals (Engg Dept.) Name Designation Signature Date Abc Pharmaceuticals (QA Dept.) APPROVED BY: Organization Abc Pharmaceuticals (HOD QA Dept.) Name Designation Signature Date Abc Pharmaceuticals (Plant Head)

Heating, ventilation, and air system encompasses heating, ventilation, and air conditioning, which is integral component of

Heating, ventilation, and air system encompasses heating, ventilation, and air conditioning, which is integral component of REVIEW ARTICLE Demand of pharmaceutical facility functionality: Validation and qualification of HVAC system Anamika Singh, Sapna Malviya, Anil Kharia Department of Quality Assurance of Modern Institute

More information

Regulatory Expectations, Standards & Guidelines

Regulatory Expectations, Standards & Guidelines Regulatory Expectations, Standards & Guidelines Regulatory Requirements Pharmacopeias Good Automated Manufacturing Practice (GAMP) 21 CFR Part 11 and Annex 11 Consequences of Non-Compliance 22 Regulatory

More information

USP Chapter 823 USP 32 (old) vs. USP 35 (new)

USP Chapter 823 USP 32 (old) vs. USP 35 (new) USP Chapter 823 USP 32 (old) vs. USP 35 (new) Sally W. Schwarz, MS, BCNP Research Associate Professor of Radiology Washington University School of Medicine St. Louis, MO Why USP Chapter ? FDA has

More information

GMP On Site Series. GMP Essentials

GMP On Site Series. GMP Essentials GMP On Site Series GMP Essentials GMP Basics Objectives 1. State the critical definitions of the pharmaceutical industry. 2. Describe the law as it applies to various critical functions. 3. State the history

More information

General European OMCL Network (GEON) QUALITY MANAGEMENT DOCUMENT

General European OMCL Network (GEON) QUALITY MANAGEMENT DOCUMENT General European OMCL Network (GEON) QUALITY MANAGEMENT DOCUMENT PA/PH/OMCL (16) 86 R2 MANAGEMENT OF ENVIRONMENTAL CONDITIONS Full document title and reference Document type Management of Environmental

More information

Equipment Qualification Ensure Fit for Intended Use. IVT Amsterdam Conference Mary Sexton. 19 Mar 2015

Equipment Qualification Ensure Fit for Intended Use. IVT Amsterdam Conference Mary Sexton. 19 Mar 2015 Equipment Qualification Ensure Fit for Intended Use IVT Amsterdam Conference Mary Sexton 19 Mar 2015 Equipment Qualification Ensure Fit for Intended Use 1. Types of Qualification 2. Validating Equipment

More information

18.H Questionnaire for preparing GMP-inspections

18.H Questionnaire for preparing GMP-inspections Questionnaire for preparing -inspections Questionnaire for preparing -inspections Here you will find answers to the following questions: What questions are typically asked during inspections based on current

More information

Annex Draft Annex

Annex Draft Annex Anmerkung 1: Dieses Vergleichsdokument wurde nach bestem Wissen und Gewissen erstellt und ist rechtlich nicht bindend. Es gelten die von der EMA veröffentlichten Dokumente in der jeweiligen Form. Anmerkung

More information

Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer

Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer Part 1: General information Name of Manufacturer Production Block Physical address Contact address Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer. Clean Utilities in the Basement.

More information

ISPE CASA Energy Management Forum - Energy Management of Capital Projects at Novartis

ISPE CASA Energy Management Forum - Energy Management of Capital Projects at Novartis ISPE CASA Energy Management Forum - Energy Management of Capital Projects at Novartis Lee Willmon, Head of Health, Safety and Environment Vaccines and Diagnostics Holly Springs, NC 16 Sept 10 Agenda Holly

More information

MicroBio MB1 IQ/OQ/PQ

MicroBio MB1 IQ/OQ/PQ Document No: MicroBio MB1 IQ/OQ/PQ Installation, Operational and Performance Qualification Protocol and Report for the MicroBio MB1 Bioaerosol Sampler Issue: 2 P0001W004 : Issue: 2 / 1 26 Cantium Scientific

More information

Quality Risk Management (ICH Q9): WHO Model for Sustainable Quality Medicines

Quality Risk Management (ICH Q9): WHO Model for Sustainable Quality Medicines Quality Risk Management (ICH Q9): WHO Model for Sustainable Quality Medicines Longe Sunday Anthony Head- Quality Assurance May & Baker Nigeria Plc. Pharmacentre, Ota, Nigeria eaglesconsult@gmail.com; Slonge@may-

More information

Supplement 7 Qualification of temperature-controlled storage areas. Technical supplement to WHO Technical Report Series, No.

Supplement 7 Qualification of temperature-controlled storage areas. Technical supplement to WHO Technical Report Series, No. Supplement 7 Qualification of temperature-controlled storage areas Technical supplement to WHO Technical Report Series, No. 961, 2011 Annex 9: Model guidance for the storage and transport of time- and

More information

ISPE Baseline Pharmaceutical Engineering Guide for New and Renovated Facilities Volume 2: Oral Solid Dosage Forms (Revision) Executive Summary

ISPE Baseline Pharmaceutical Engineering Guide for New and Renovated Facilities Volume 2: Oral Solid Dosage Forms (Revision) Executive Summary Reprinted from PHARMACEUTICAL ENGINEERING The Official Magazine of ISPE September/October 2008, Vol. 28 No. 5 This executive summary provides an overview of the second edition of the ISPE Baseline Guide:

More information

WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer. Mylan Nashik ( Sinnar in CRM) AND

WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer. Mylan Nashik ( Sinnar in CRM) AND SOP 408.4 Annex D 20, avenue Appia CH-1211 Geneva 27 Switzerland Tel central +41 22 791 2111 Fax central +41 22 791 3111 www.who.int WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer

More information

Your partner in the pharmaceutical industry

Your partner in the pharmaceutical industry English Micronisation- and milling service Micronised by GfM Your API Particle size (µm) Your partner in the pharmaceutical industry The... always that little bit finer. We are a family business in the

More information

CUSTOMER AND SUPPLIER ROLES AND RESPONSIBILITIES FOR 21 CFR 11 COMPLIANCE ASSESSMENT. 21 CFR Part 11 FAQ. (Frequently Asked Questions)

CUSTOMER AND SUPPLIER ROLES AND RESPONSIBILITIES FOR 21 CFR 11 COMPLIANCE ASSESSMENT. 21 CFR Part 11 FAQ. (Frequently Asked Questions) 21 CFR Part 11 FAQ (Frequently Asked Questions) Customer and Supplier Roles and Responsibilities for Assessment of METTLER TOLEDO STARe Software Version 16.00, including: - 21 CFR 11 Compliance software

More information

ASEAN Guidelines on GMP for Traditional Medicines / Health Supplement

ASEAN Guidelines on GMP for Traditional Medicines / Health Supplement ASEAN Guidelines on GMP for Traditional Medicines / Health Supplement Prepared by: PHILIPPINES Approved by: ASEAN TMHS GMP Task Force Endorsed by: ASEAN TMHS Product Working Group OUTLINE 1. Principle

More information

Overview of Amgen s CQP Commissioning and Qualification Program Steve Wisniewski Principal Compliance Consultant, CAI Past Chairman ISPE C&Q COP

Overview of Amgen s CQP Commissioning and Qualification Program Steve Wisniewski Principal Compliance Consultant, CAI Past Chairman ISPE C&Q COP May 1-3, 2012 Javits Center New York, NY Introduction to ISPE GUIDE: SCIENCE AND RISK-BASED APPROACH FOR THE DELIVERY OF FACILITIES, SYSTEMS, AND EQUIPMENT & Overview of Amgen s CQP Commissioning and Qualification

More information

Conducting Supplier Audits: Ensure Validation Compliance

Conducting Supplier Audits: Ensure Validation Compliance Conducting Supplier Audits: Ensure Validation Compliance Presented by: Gamal Amer, Ph. D. Principal Premier Compliance Services, Inc. All rights reserved. Do not copy without permission. 1 Outline Why

More information

Preparing Your Aseptic Processing Facility for an FDA Inspection. Valerie Welter, Director Quality Bayer HealthCare March 10, 2014

Preparing Your Aseptic Processing Facility for an FDA Inspection. Valerie Welter, Director Quality Bayer HealthCare March 10, 2014 Preparing Your Aseptic Processing Facility for an FDA Inspection Valerie Welter, Director Quality Bayer HealthCare March 10, 2014 Agenda Regulatory Requirements Establishing your Approach Aseptic Controls

More information

Environmental Monitoring of Aseptic Processing Areas - 1

Environmental Monitoring of Aseptic Processing Areas - 1 Environmental Monitoring of Aseptic Processing Areas - 1 A war against an invisible enemy DCVMN - Víctor Maqueda - May 30, 31, June 1 2016 1 Training Course Agenda Overview of Environmental Monitoring

More information

Risk-based Approach to Part 11 and GxP Compliance

Risk-based Approach to Part 11 and GxP Compliance Welcome to our E-Seminar: Risk-based Approach to Part 11 and GxP Compliance 1 Intro Common Discussion Q: Do I really need to do this? Possible Answers A: Of course! (QA) B: Who cares, I have work to do!

More information

Guidelines for Process Validation of Pharmaceutical Dosage Forms

Guidelines for Process Validation of Pharmaceutical Dosage Forms Guidelines for Process Validation of Pharmaceutical Dosage Forms Version 2.1 Date issued 21/02/2010 Date of implementation 21/05/2010 31 August 2010 Page 1 of 20 Guidelines for Process Validation of Pharmaceutical

More information

Validation. An Easy to Understand Guide Validating Purified Water Systems

Validation. An Easy to Understand Guide Validating Purified Water Systems Validation Overview Validation Documentation Validation Activities Validation Mistakes Validation Protocols Test Selection Common Verifications When to test Test Layout and Content Validation Protocol

More information

Comparison of Guidelines of Indian GMP with WHO GMP

Comparison of Guidelines of Indian GMP with WHO GMP Comparison of Guidelines of Indian GMP with WHO GMP By Dr. Uma Vasireddy, M.Pharm,Ph.D.., Professor and Principal, KIPS,Wgl, INDIA 1 Outline of Presentation Introductory Elements Section wise Comparison

More information

DESIGN & CONSTRUCTION PHASE COMMISSIONING PLAN TEMPLATE

DESIGN & CONSTRUCTION PHASE COMMISSIONING PLAN TEMPLATE DESIGN & CONSTRUCTION PHASE COMMISSIONING PLAN TEMPLATE Based upon B3 Minnesota Sustainable Building Guidelines VERSION 2.1 Notes to the reader have been added to this document within numerous text boxes

More information

DESIGN BASIS FOR AIR CONDITIONING AND VENTILATION SYSTEM FOR SUBSTATION AND CONTROL BUILDING HINDUSTAN PETROLEUM CORPORATION LTD.

DESIGN BASIS FOR AIR CONDITIONING AND VENTILATION SYSTEM FOR SUBSTATION AND CONTROL BUILDING HINDUSTAN PETROLEUM CORPORATION LTD. CONDITIONING AND VENTILATION FOR SUBSTATION AND CONTROL BUILDING HINDUSTAN PETROLEUM CORPORATION LTD. VISAKH REFINERY DHT PROJECT TEIL JOB NO.: 6261 DOCUMENT NO.: 6261-HVAC-PKG-300 TEIL SPECIFICATION NO.:---

More information

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY ISSN Review Article

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY  ISSN Review Article INTERNATIONAL RESEARCH JOURNAL OF PHARMACY www.irjponline.com ISSN 2230 8407 Review Article INTRODUCTION AND GENERAL OVERVIEW OF PHARMACEUTICAL PROCESS VALIDATION: A REVIEW Pandita Rachna* 1, Rana A C

More information

Persistence Tracking in a Retro-commissioning Program

Persistence Tracking in a Retro-commissioning Program Persistence Tracking in a Retro-commissioning Program Mike Eardley Architectural Energy Corporation Synopsis The persistence of energy savings and electrical demand reductions created by retrocommissioning

More information

Inspections, Compliance, Enforcement, and Criminal Investigations

Inspections, Compliance, Enforcement, and Criminal Investigations Page 1 of 8 Inspections, Compliance, Enforcement, and Criminal Investigations Lupin Limited 5/7/09 Department of Health and Human Services Public Health Service Food and Drug Administration CENTER FOR

More information

Facility and Equipment Maintenance

Facility and Equipment Maintenance Facility and Equipment Maintenance Deborah L. Griffin Manager, Quality Assurance for Cellular Therapies Hillman Cancer Center University of Pittsburgh Cancer Institute University of Pittsburgh Medical

More information

Mission Critical Commissioning for Healthcare Facilities

Mission Critical Commissioning for Healthcare Facilities Mission Critical Commissioning for Healthcare Facilities Steven R. Rusty Ross SSRCx, LLC Synopsis Healthcare Facilities serve a critical and unique mission. Few facilities delivered by the construction

More information

Microbiological Consideration for Non-Sterile Pharmaceutical

Microbiological Consideration for Non-Sterile Pharmaceutical May 1-3, 2012 Javits Center New York, NY Microbiological Consideration for Non-Sterile Pharmaceutical Dr. Leonard W. Mestrandrea Principal Consultant MESTRANDREA CONSULTING LLC Title Date Microbial Control

More information

Temperature Mapping Report

Temperature Mapping Report Document Status: Page: 1 of 13 Temperature Mapping Report Company Name & Site Warehouse Start Date: DD Month YYYY End Date: DD Month YYYY Document Status: Page: 2 of 13 Table of Contents 1 Approvals...

More information

Performance Qualification Protocol Prepared March 2008

Performance Qualification Protocol Prepared March 2008 Protocol #: PQP- xxx Ver 01 Gismo Heat Sealer Page 1 of 6 Performance Qualification Protocol Prepared March 2008 Title Heat Sealer Validation Products Sterile Gizmos Codes 12345 through 12789 Equipment/Process

More information

Efficient Validation Strategies and VMPs

Efficient Validation Strategies and VMPs FDA Medical Device Industry Coalition Efficient Validation Strategies and VMPs Anne Holland Wilson Agenda History and Recent Trends Why Validate 21 CFR 820.75 Process Validation Standards and Guidance

More information

for IND and RDRC Regulated PET Compounding

for IND and RDRC Regulated PET Compounding Overview of USP Chapter for IND and RDRC Regulated PET Compounding Distributed Manufacturing of PET Radiopharmaceuticals for Multi-Center Clinical Trials SNM, Annual Meeting Toronto, Ontario, Canada

More information

Temperature Mapping Study of Walk-in incubator in a Pharma Industry

Temperature Mapping Study of Walk-in incubator in a Pharma Industry Research Article Temperature Mapping Study of Walk-in incubator in a Pharma Industry Harish Gowda G.S, Gangadharappa H.V*, Kiran H.C, Naveen Kumar V Department of Pharmaceutics (Pharmaceutical Quality

More information

Introduction to GMPs and Validation WILLIAM GARVEY AND ASSOCIATES

Introduction to GMPs and Validation WILLIAM GARVEY AND ASSOCIATES Introduction to GMPs and Validation WILLIAM GARVEY AND ASSOCIATES William Garvey and Associates LLC 2016 Introduction About your instructor William (Bill) Garvey Important regulations and events Good Manufacturing

More information

35 STATION DOUBLE ROTORY COMPRESSION MACHINE

35 STATION DOUBLE ROTORY COMPRESSION MACHINE Page 1 of 16 User Requirement Specifications 35 STATION DOUBLE ROTORY Equipment ID: T-35COMP 01 Page 2 of 16 Table of Contents 1.0 APPROVAL SIGNATURES 2.0 OVERVIEW 3.0 PROCESS DESCRIPTION 4.0 PRODUCTIVITY

More information

Process validation in medical devices

Process validation in medical devices Process validation in medical devices Fulfil requirements with expert regulatory guidance 1TÜV SÜD Contents INTRODUCTION 4 VALIDATION PLANNING 5 INSTALLATION QUALIFICATION 7 OPERATIONAL QUALIFICATION 9

More information

American Association for Laboratory Accreditation

American Association for Laboratory Accreditation Page 1 of 34 This checklist is intended for use in association with A2LA assessments, and is not to be publicly distributed. Use of this document is restricted to A2LA employees, contractors, and applicant

More information

INS QA Programme Requirements

INS QA Programme Requirements Specification Date: 20/3/17 INS QA Programme Requirements UNCONTROLLED WHEN PRINTED Author: J Cooch AUTHORISATION Date: 20/3/17 A Brown Owner: J Cooch (Signature) N.B. only required for hard copy If issued

More information

Permanent Load Shifting Program

Permanent Load Shifting Program 1. Program Description Permanent Load Shifting (PLS) can help reduce system peak load by storing energy produced during off-peak period and shifting electricity use from on-peak to off-peak periods on

More information

Basics Of Labwasher Cleaning Validation

Basics Of Labwasher Cleaning Validation Basics Of Labwasher Cleaning Validation A Q&A With James Espiritu, Laboratory Equipment Business Applications Manager, Miele Validation is vital to pharmaceutical processes because it assures quality,

More information

Available online at ScienceDirect. Procedia Engineering 132 (2015 )

Available online at  ScienceDirect. Procedia Engineering 132 (2015 ) Available online at www.sciencedirect.com ScienceDirect Procedia Engineering 132 (2015 ) 811 815 The Manufacturing Engineering Society International Conference, MESIC 2015 Metrological Regulations for

More information

Reviewers, approvers and executers of this plan are captured in the approval routing tab of this document in IFS.

Reviewers, approvers and executers of this plan are captured in the approval routing tab of this document in IFS. DOCUMENT NUMBER: 1034722 LOCATION: FT COLLINS/LOVELAND PAGE 1 of 8 1.0 PURPOSE 1.1 The purpose of this Validation Master Plan (VMP) is to identify the validation and testing requirements necessary to qualify

More information

Agilent Resources for Workflow Compliance MEASURING ELEMENTAL IMPURITIES IN PHARMACEUTICAL MATERIALS

Agilent Resources for Workflow Compliance MEASURING ELEMENTAL IMPURITIES IN PHARMACEUTICAL MATERIALS Agilent Resources for Workflow Compliance MEASURING ELEMENTAL IMPURITIES IN PHARMACEUTICAL MATERIALS AGILENT SOLUTIONS USP / & ICH Q3D Implementing Elemental Impurities Tests in the Pharmaceutical

More information

Hot Topics in Drug Product Process Validation: A Reviewer s Perspective

Hot Topics in Drug Product Process Validation: A Reviewer s Perspective Hot Topics in Drug Product Process Validation: A Reviewer s Perspective Colleen Thomas, Ph.D. Quality Assessment Lead (Acting) FDA/CDER/OPQ/OPF Division of Microbiology Assessment CASSS CMC Strategy Forum

More information

Retro-Commissioning for Existing Facilities

Retro-Commissioning for Existing Facilities Retro-Commissioning for Existing Facilities Tom Meyer Director, Technical Programs National Environmental Balancing Bureau 8575 Grovemont Circle Gaithersburg, Maryland 20877 (301) 977-3698 www.nebb.org

More information

FDA s Guidance for Industry

FDA s Guidance for Industry Sterile Drug Products Produced by Aseptic Processing - CGMPs Midwest FDC Conference November 4 2005 Susan Bruederle, Investigator FDA / ORA / Central Region Chicago District / Hinsdale IL FDA s Guidance

More information

Large University Central Chiller Plant Design Considerations

Large University Central Chiller Plant Design Considerations Carrier Engineering Newsletter Volume 5, Issue 3 Large University Central Chiller Plant Design Considerations Large campus chilled water plants have unique constraints and need careful evaluation for successful

More information

Implementation Life-cycle SOP

Implementation Life-cycle SOP 1.0 Commercial in Confidence 11-Aug-2006 1 of 12 Implementation Life-cycle SOP Document No: H4_SOP_0100 Prepared by: David Brown Date: 11-Aug-2006 Version: 1.0 1.0 Commercial in Confidence 11-Aug-2006

More information

Chilled Water System Optimization

Chilled Water System Optimization Advanced HVAC Diagnostics and Control Strategies Chilled Water System Optimization Brian Leduc Carrier Corporation August 16, 2017 Contents of this presentation 2017 Carrier Corporation Tampa Convention

More information

SECTION AIR DUCT CLEANING

SECTION AIR DUCT CLEANING PART 1 - GENERAL 1.1 RELATED DOCUMENTS A. Drawings and general provisions of the Contract, including General and Supplementary Conditions and Specification Sections, apply to this Section. B. Related Sections:

More information

Draft Indoor Air Quality Regulations

Draft Indoor Air Quality Regulations Department of Environment and Labour Occupational Health and Safety Division Draft Indoor Air Quality Regulations May, 2001 These draft regulations are being distributed for public comment. They do NOT

More information

PROCESS VALIDATION: AN ESSENTIAL PROCESS IN PHARMACEUTICAL INDUSTRY

PROCESS VALIDATION: AN ESSENTIAL PROCESS IN PHARMACEUTICAL INDUSTRY WORLD JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES Vijayasree et al. SJIF Impact Factor 6.647 Volume 6, Issue 3, 367-874 Review Article ISSN 2278 4357 PROCESS VALIDATION: AN ESSENTIAL PROCESS IN PHARMACEUTICAL

More information

Building Management Systems (BMS)

Building Management Systems (BMS) This article presents practical riskbased advice regarding the implementation and management of computerized aspecis of a Building Management System. Reprinted from The Official Journal of ISPE PHARMACEUTICAL

More information

GMPs: Distribution Centers

GMPs: Distribution Centers SkillsPlus International Inc. The On-Site Series GMPs: Distribution Centers Learn to apply the GMP regulations as they relate to distribution center operations! FDA Past, Present, and Future and opener

More information

Validation Study on How to Avoid Microbial Contamination during Pharmaceutical Production

Validation Study on How to Avoid Microbial Contamination during Pharmaceutical Production Biocontrol Science, 2015, Vol. 20, No.1, 1 10 Review Validation Study on How to Avoid Microbial Contamination during Pharmaceutical Production HIDEHARU SHINTANI 1-13-27, Kasuga, Bunkyo, Tokyo 112-0003,

More information

ISO INTERNATIONAL STANDARD. Cleanrooms and associated controlled environments Part 4: Design, construction and start-up

ISO INTERNATIONAL STANDARD. Cleanrooms and associated controlled environments Part 4: Design, construction and start-up INTERNATIONAL STANDARD ISO 14644-4 First edition 2001-04-01 Cleanrooms and associated controlled environments Part 4: Design, construction and start-up Salles propres et environnements maîtrisés apparentés

More information

EU and FDA GMP Regulations: Overview and Comparison

EU and FDA GMP Regulations: Overview and Comparison THE QUALITY ASSURANCE JOURNAL, VOL. 2, 55 60 (1997) EU and FDA GMP Regulations: Overview and Comparison The increasing emphasis on global supply of drug products, as well as starting materials and investigational

More information

ISO INTERNATIONAL STANDARD

ISO INTERNATIONAL STANDARD INTERNATIONAL STANDARD ISO 14644-2 First edition 2000-09-15 Cleanrooms and associated controlled environments Part 2: Specifications for testing and monitoring to prove continued compliance with ISO 14644-1

More information

Attachment 1 Amendment 6 - IS6/IAS6: Section 3.8: Amended New Zealand Standard for Spray Chilling Large Mammals and Large Birds

Attachment 1 Amendment 6 - IS6/IAS6: Section 3.8: Amended New Zealand Standard for Spray Chilling Large Mammals and Large Birds Attachment 1 Amendment 6 - IS6/IAS6: Section 3.8: Amended New Zealand Standard for Spray Chilling Large Mammals and Large Birds February 2008 Contents 1 Scope... 2 2 Background... 2 3 Definitions... 3

More information

ASEPTIC BIOPHARMACEUTICAL MANUFACTURING: FAQs

ASEPTIC BIOPHARMACEUTICAL MANUFACTURING: FAQs ASEPTIC BIOPHARMACEUTICAL MANUFACTURING: FAQs THE BIOTRAK REAL-TIME VIABLE PARTICLE COUNTER UNDERSTANDING, ACCELERATED REDUCE RISK INCREASE EFFICIENCY IMPROVE PROCESS UNDERSTANDING The BioTrak Real-Time

More information

ABSTRACT: VENTILATION The European Commission, Energy Performance of Buildings Directive, and its Ventilation Implications. Eric Curd.

ABSTRACT: VENTILATION The European Commission, Energy Performance of Buildings Directive, and its Ventilation Implications. Eric Curd. ABSTRACT: VENTILATION. 2006. The European Commission, Energy Performance of Buildings Directive, and its Ventilation Implications. Eric Curd. Consulting Engineer. UK. This paper considers the ventilation

More information

Strategies for Risk Based Validation of Laboratory Systems

Strategies for Risk Based Validation of Laboratory Systems Strategies for Risk Based Validation of Laboratory Systems Video Web Seminar September 23, 2004 Ludwig Huber E-mail: ludwig_huber@agilent.com Today s Agenda Background information: why risk assessment,

More information

Industry Perspective on Manufacturing in Early Development

Industry Perspective on Manufacturing in Early Development Industry Perspective on Manufacturing in Early Development IQ Workshop, Feb 4-5, 2014, Washington, D.C. Eric Schmitt AbbVie IQ Drug Product Manufacturing Working Group August 2012 issue of Pharmaceutical

More information

The validation of biological Active Pharmaceutical

The validation of biological Active Pharmaceutical This article presents a procedure for the validation of biological API manufacturing processes. It details each step of the procedure for biological processes applications, and covers the regulatory requirements

More information

Review Validation of aseptic processes for pharmaceuticals

Review Validation of aseptic processes for pharmaceuticals OPEM www.opem.org Oriental Pharmacy and Experimental Medicine 2010 10(4), 231-238 DOI 10.3742/OPEM.2010.10.4.231 Review Validation of aseptic processes for pharmaceuticals Lincy Joseph*, Mathew George

More information

Tank Scale Service Checklist

Tank Scale Service Checklist Tank Scale Service Checklist Specifying Service for Optimized Weighing Processes Selecting the right weighing equipment is an important first step to ensuring that your weighing processes are able to meet

More information

CALIBRATION AND QUALIFICATION OF EQUIPMENTS IN THE PHARMACEUTICAL INDUSTRY: EMPHASIS ON RADIOPHARMACEUTICALS PRODUCTION

CALIBRATION AND QUALIFICATION OF EQUIPMENTS IN THE PHARMACEUTICAL INDUSTRY: EMPHASIS ON RADIOPHARMACEUTICALS PRODUCTION 2011 International Nuclear Atlantic Conference - INAC 2011 Belo Horizonte, MG, Brazil, October 24-28, 2011 ASSOCIAÇÃO BRASILEIRA DE ENERGIA NUCLEAR - ABEN ISBN: 978-85-99141-04-5 CALIBRATION AND QUALIFICATION

More information

DRAWING NUMBER REVISION TITLE REV DATE PAGE

DRAWING NUMBER REVISION TITLE REV DATE PAGE DRAWING NUMBER REVISION TITLE REV DATE PAGE 90-2000-7.5.1 C PRODUCT RESOURCES NEWBURYPORT, MA Control of Production and 11/2016 1 of 5 NOTICE: THIS DOCUMENT IS PROPRIETARY AND ITS CONTENTS ARE THE EXCLUSIVE

More information

Trinity College Dublin QP Forum 2017 Tuesday 25 th April

Trinity College Dublin QP Forum 2017 Tuesday 25 th April Trinity College Dublin QP Forum 2017 Tuesday 25 th April HPRA QUESTIONS & ANSWERS 1. What is the approach being taken for audit of contamination control strategies as per chapters 3 & 5? What is the current

More information

Building & Ductwork Airtightness Standards

Building & Ductwork Airtightness Standards Building & Ductwork Airtightness Standards Version 1.02, August 2013 Standard Reference Technical Body Title ICS (International Classification for Standards) Scope Door and Windows EN 12207:1999 Windows

More information

Mechanical Product Overview

Mechanical Product Overview Mechanical Product Overview The founding principles of Price have never changed business integrity, first class service, innovation and a commitment to people. PURPOSE BUILT FOR YOUR APPLICATION Whether

More information

F-Series 1 Elements Performance Validation

F-Series 1 Elements Performance Validation F-Series 1 Elements Performance Validation An independent test report validating the performance of the nano F-Series 1 Compressed Air & Gas Filter Elements to ISO 12500-1:2007 air quality standards. Conducted

More information

Supplier Quality Survey

Supplier Quality Survey Supplier Quality Survey Smiths Interconnect Lorch Microwave assumes a basic responsibility for the quality of all contract end items produced under its direction. Since the quality of purchased and sub-contracted

More information

Baffled Openings at Chain Link Fencing: Design shall consist of two end-posts set 4 feet apart, and a 10 foot wide chain-link fence panel equal in height as the adjacent fence. Chain link fence panel shall

More information

Ehsan Soltani. Date of Birth: 1 Sep, 1980 Nationality: Iranian Marital Status: Married Mobile :(+98)

Ehsan Soltani. Date of Birth: 1 Sep, 1980 Nationality: Iranian Marital Status: Married   Mobile :(+98) Ehsan Soltani Date of Birth: 1 Sep, 1980 Nationality: Iranian Marital Status: Married E-mail: ehsan.soltani@gmail.com Mobile :(+98) - 912-1501764 CAREER BRIEF: Having over 15 Years Work Experience in Iran

More information

Application of Quality Risk Management Tools for Cell Therapy Manufacturing

Application of Quality Risk Management Tools for Cell Therapy Manufacturing Application of Quality Risk Management Tools for Cell Therapy Manufacturing 17 th ISCT Annual Meeting May 20, 2011 Jean Stanton Associate Director, Product Quality Management Janssen Supply Chain Conflict/Disclaimer

More information

INDUSTRIAL PROCESS VALIDATION OF TABLET DOSAGE FORM: A REVIEW

INDUSTRIAL PROCESS VALIDATION OF TABLET DOSAGE FORM: A REVIEW International Journal of Pharmacy Review & Research www.ijprr.com INDUSTRIAL PROCESS VALIDATION OF TABLET DOSAGE FORM: A REVIEW Vishal Sharma* and Nimrata Seth 1 Department of Pharmaceutics, Rayat Institute

More information

CHILLED WATER DISTRIBUTION SYSTEM

CHILLED WATER DISTRIBUTION SYSTEM Campus-Wide System: A campus-wide central chilled water system has been developed in recent years and is being expanded to serve additional cooling loads as need arises and opportunity affords. This system

More information

The 10 Golden Rules of GMP

The 10 Golden Rules of GMP The Good Manufacturing Practice regulations that govern pharmaceutical and medical device manufacturing can seem overwhelming. Use these ten golden rules to drive your day-to-day operations, keeping them

More information

ASQ FD&C GMP Quality Conference

ASQ FD&C GMP Quality Conference ASQ FD&C GMP Quality Conference End User Testing for Performance Qualification of GXP/ Part 11 Systems Off The Shelf (OTS) Dr. Teri Stokes, GXP International, Concord, MA USA www. GXPInternational.com

More information

On-Site GMP Training GMP COMPLIANCE TECHNICAL

On-Site GMP Training GMP COMPLIANCE TECHNICAL PharmaNet On-Site GMP Training GMP COMPLIANCE TECHNICAL 284 E Lake Mead Pkwy Suite C-278 Henderson, NV 89015 Phone: 702-558-0094 Fax: 702-558-0079 www.gmpseminars.com Key to Level of Program Level A: Program

More information

Valent Packaged Rooftop Units A Fresh Choice for High-Percentage Outdoor Air Designs. Valent is a business of Unison Comfort Technologies.

Valent Packaged Rooftop Units A Fresh Choice for High-Percentage Outdoor Air Designs. Valent is a business of Unison Comfort Technologies. Valent Packaged Rooftop Units A Fresh Choice for High-Percentage Outdoor Air Designs Valent is a business of Unison Comfort Technologies. When your HVAC system design calls for high-percentage or 100%

More information

Regional GMP Strengthening Workshop for Indian Pharmaceutical Manufacturers and State Regulators

Regional GMP Strengthening Workshop for Indian Pharmaceutical Manufacturers and State Regulators Regional GMP Strengthening Workshop for Indian Pharmaceutical Manufacturers and State Regulators Focused on GMP in production of Active Pharmaceutical Ingredients and Oral Solid Dosage Forms Organized

More information

Version 1.0 August 30, 2017

Version 1.0 August 30, 2017 Supplier Requirements Guideline 1.0 Purpose The purpose of this Supplier Requirements Guideline is to provide a guidance document with the expectations and requirements Baxter has of its suppliers. The

More information

B. ASHRAE 1991 HVAC Applications Handbook: Chapter 34--Testing, Adjusting and Balancing.

B. ASHRAE 1991 HVAC Applications Handbook: Chapter 34--Testing, Adjusting and Balancing. PART 1 GENERAL 1.1 RELATED DOCUMENTS SECTION 230593 TESTING, ADJUSTING, AND BALANCING A. Drawings and general provisions of Contract, including General and Supplementary Conditions and Division 1 Specification

More information

Containment Booths. FOR MORE INFORMATION ON CONTAINMENT BOOTHS CALL +44 (0) OR

Containment Booths. FOR MORE INFORMATION ON CONTAINMENT BOOTHS CALL +44 (0) OR www.extract-technology.com ENGINEERED CONTAINMENT SOLUTIONS Containment Booths AT Extract Technology, we provide complete containment solutions based around an innovative range of Downflow Containment

More information

Design Qualification SOP

Design Qualification SOP 1.0 Commercial in Confidence 16-Aug-2006 1 of 13 Design Qualification SOP Document No: SOP_0400 Prepared by: David Brown Date: 16-Aug-2006 Version: 1.0 1.0 Commercial in Confidence 16-Aug-2006 2 of 13

More information

References Concept. Principle. EU Annex 11 US FDA , (g), (i), 11 Orlando Lopez 2/15/11. Old Annex 11.

References Concept. Principle. EU Annex 11 US FDA , (g), (i), 11 Orlando Lopez 2/15/11. Old Annex 11. References Concept Principle a. This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components which

More information

Hazard Analysis and Critical Control Point The Almond Board of California. Overview. Definitions

Hazard Analysis and Critical Control Point The Almond Board of California. Overview. Definitions Hazard Analysis and Critical Control Point The Almond Board of California Overview Hazard Analysis Critical Control Point (HACCP) is the final stage of an integrated, proactive food safety program targeting

More information

Quality Assurance QA STANDARD OPERATING PROCEDURE FOR FDA or Pharmaceutical Sponsored Audits

Quality Assurance QA STANDARD OPERATING PROCEDURE FOR FDA or Pharmaceutical Sponsored Audits Quality Assurance QA 601.01 STANDARD OPERATING PROCEDURE FOR FDA or Pharmaceutical Sponsored Audits Approval: Nancy Paris, MS, FACHE President and CEO 24 May 2017 (Signature and Date) Approval: Frederick

More information

GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PART I

GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PART I PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PE 009-11 (Part I) 1 March 2014 GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PART I PIC/S March 2014 Reproduction

More information

PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7:NON-STERILE PROCESS VALIDATION

PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7:NON-STERILE PROCESS VALIDATION 1 Working document QAS/13.527/Rev.2 August 2014 RESTRICTED 2 3 4 5 6 7 8 9 10 PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7:NON-STERILE PROCESS

More information

Current Features of USFDA and EMA Process Validation Guidance

Current Features of USFDA and EMA Process Validation Guidance Human Journals Review Article April 2016 Vol.:6, Issue:1 All rights are reserved by Patwekar S.L et al. Current Features of USFDA and EMA Process Validation Guidance Keywords: Pharmaceutical validation,

More information

PhEn-602 Notes # 4 J. Manfredi

PhEn-602 Notes # 4 J. Manfredi PhEn-602 Notes # 4 J. Manfredi Spring 2009 1 Basic definitions Clean Room: A room in which the concentration of airborne particles is controlled and contains one or more clean zones Clean Zone: A defined

More information